Real-world renal function among patients with multiple myeloma in the United States

[1]  M. Dimopoulos,et al.  Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis , 2020, Leukemia.

[2]  S. Baxi,et al.  Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health, SEER, and NPCR , 2020 .

[3]  Joshua Haimson,et al.  Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research , 2020, ArXiv.

[4]  S Vincent Rajkumar,et al.  Multiple myeloma: 2016 update on diagnosis, risk‐stratification, and management , 2016, American journal of hematology.

[5]  H. Goldschmidt,et al.  Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  R. Neuwirth,et al.  Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study , 2008, Leukemia.

[7]  C. Schmid,et al.  Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[9]  T. Economopoulos,et al.  Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance , 2007, Leukemia & lymphoma.

[10]  M. Dimopoulos,et al.  Renal Failure in Multiple Myeloma: Incidence, Correlations and Prognostic Significance. , 2006 .

[11]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[12]  R. Soutar,et al.  Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. , 1999, Blood reviews.

[13]  O. Cope,et al.  Multiple myeloma. , 1948, The New England journal of medicine.